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Abstract We studied the terminal events preceding death in all patients dying in
hospital over a period of 10 years. Hepatomegaly, massive ascites, cachexia,
jaundice, massive pleural effusion and haemoptysis were themost frequent terminal
events. The predominance of visceral-related terminal events is unexplained
but may be related to site-specific metastasis and premorbid organ pathology.
ª 2005 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.Introduction
Over 70% of breast cancer patients in Africa are
seen for the first time when the disease is already
in the advanced stage.1 Therefore, a large pro-
portion of diagnostic as well as therapeutic inter-
ventions are carried out on patients who are
already in the terminal stages of the disease. The
5-year survival for breast cancer patients in Africa
is between 15 and 30%.2 This is very low compared
to over 60% 5-year survival in most developed
countries.3 This disparity has often been attributed
to late presentation.1,2 However, it is possible
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low survival from breast cancer in Africa. A periodic
analysis of the terminal events preceding death in
breast cancer patients may provide insight into the
biology of the malignant process and also provide
guidelines for further research on supportive care
for these stages of the disease.
The aim of this study was to identify the specific
terminal events preceding death with a view to
understanding more and suggesting ways of im-
proving on our management of terminal breast
cancer patients.
Methods
We reviewed all cases of terminal breast cancer
dying in Jos University Teaching Hospital overblished by Elsevier Ltd. All rights reserved.
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period, 376 patients were seen with breast cancer,
266 (70.7%) were thought to be advanced. One
hundred and eighty patients were admitted with
terminal disease. Only 84 (46%) of them died in
hospital. Those who left did so after the prognosis
was explained to them or their relations, and
preferred to die at home than remain in the
hospital. Dominant clinical features occurring
within 7 days of death were studied in the patients
who remained. These were considered to be the
terminal events preceding death. All patients were
treated with combination chemotherapy including
methotrexate, cyclophosphamide and 5-fluoroura-
cil (CMF). Ten of them had simple mastectomy and
radiotherapy to control local disease. Twenty had
simple mastectomy alone. The rest had only di-
agnostic procedures like excision biopsy or pallia-
tive procedures like chest intubation because of
the advanced stage of their disease. No postmor-
tems were done.
Results
Eighty percent of the patients dying in hospital
were being seen by the breast unit for the first
time. Hepatomegaly, massive ascites, cachexia
and jaundice together were seen in 20 patients.
Massive pleural effusion with respiratory embar-
rassment was seen in 12, headache confusion and
loss of consciousness in 10, massive haemoptysis
and exsanguinations in 8, paraplegia, bed sores
and sepsis in 6, pathological fractures, and sepsis
in 6, sudden deterioration and death following
chemotherapy in another 6 patients (see Table 1).
Other terminal events include: repeated convul-
sions, dehydration, severe anaemia, and multiple
organ failure. Over 50% of the patients died in
severe pains necessitating the use of parenteral
opiates and 20% were depressed and withdrawn.
Discussion
Only 46% of patients dying of terminal breast
cancer did so under hospital care. The reasons for
patients’ preference of dying elsewhere in our
society has not been studied. The cost of terminal
care, religious and traditional beliefs may play
a role.4 Unfortunately, in our society, this leads to
patients and relations leaving hospital care, and
dying at home or in native herbal homes (treatment
centres operated by herbalists who used herbal
concoctions as remedies for various ailments) in
severe pains, sepsis, depression and isolation.A majority of our patients presented with
features supportive of visceral metastasis. This
has been associated with shorter time to pro-
gression and overall survival.5 The seed and soil
hypothesis as originally proposed by Paget6 where
the soil represents the specific organ microenvi-
ronment may be true in these cases. Apart from
tumour cell characteristics that may predict the
organ to which cells metastasize to,7 we want to
hypothesize that endemic malnutrition and back-
ground chronic liver disease8 may be responsible
for the predilection of the liver as the most
frequent source of terminal morbidity and mortal-
ity in our environment. There is a need to confirm
and identify markers of such predilection. A pre-
vious study in Nigeria found that only 24% of breast
cancer material expressed the oestrogen receptor
protein.9 This may also explain the predilection of
the liver as a possible site for metastasis.10
Sudden deterioration following chemotherapy
was experienced by 7.1% of our patients. This is
unexplained but may be related to increased
toxicity relating to patient premorbid status.11
Specific areas of intervention that may improve
outcome for the African patient with breast cancer
include early detection by encouraging breast self
examination by women and trained health care
assistants,12,13 nutritional support and improved
blood transfusion services. Internal fixation of
pathological fracture and early mobilization may
reduce morbidity associated with prolonged im-
mobilization in bed. Rapid and effective treatment
of infection and organ support are areas of in-
tervention that may improve the management of
the terminal breast cancer patient in Africa. Since
Table 1 Terminal events in women dying of breast
cancer
Terminal event Cases Percentage
Hepathomegaly, massive ascites,
cahexia and jaundice
20 23.8
Massive pleural effusion
and respiratory failure
12 14.3
Confusion, severe headache
and loss of consciousness
10 11.9
Severe anaemia 8 9.5
Massive haemoptysis
and exsanguinations
8 9.5
Paraplegia, bed sore and sepsis 6 7.1
Sudden deterioration
following chemotherapy
6 7.1
Pathological fractures and sepsis 6 7.1
Multiple system organ failure 5 6.0
Repeated convulsions 3 3.6
Total 84 100
Terminal events in women dying of advanced breast cancer 119over 50% of our patients prefer to die at home than
in the hospital, supervised ambulatory home care
to provide services like pain relief, antibiotic and
nutritional advice may help support these patients
through the terminal stages of breast cancer.
Breast cancer incidence is on the increase in
Africa due to several factors including changes in
diet and life style.14 Without a concomitant im-
provement in health care services, mortality for
breast cancer will predictably rise. Improvement
of general health education, patients’ access to
health care, availability of simple surgical treat-
ment and adjuvant therapy will improve the
prognosis for the breast cancer patients in Africa.
Conclusion
Hepatomegaly, massive ascites, cahexia, jaundice,
pleural effusion and massive haemoptysis are the
commonest terminal events preceding death in our
study. Over half of our terminally ill breast cancer
patients prefer to die at home than in the hospital.
Organ support and ambulatory home care may
have a place in the terminal care of breast cancer
in Africa.
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